ARMO Biosciences Inc logo

ARMO - ARMO Biosciences Inc Share Price

$49.98 0.0  0.0%

Last Trade - 21/06/18

Sector
Healthcare
Size
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £n/a
Position in Universe th / 6543
Bullish
Bearish
Unlock ARMO Revenue
Momentum
Relative Strength (%)
1m -2.60%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2012 2013 2014 2015 2016 2017 2018E 2019E CAGR / Avg
0.000 0.000 0.000 0.000 0.000 0.000
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the three months ended 31 March 2018, ARMOBiosciences Inc revenues was not reported. Net lossincreased from $9.4M to $21.7M. Higher net loss reflectsResearch & Development Expense - Balan increase from $7.6Mto $18.6M (expense), Selling, General & AdministrativeExpen increase of 64% to $2.6M (expense), Stock-basedCompensation in SGA increase from $103K to $485K (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

ARMO Revenue Unlock ARMO Revenue

Net Income

ARMO Net Income Unlock ARMO Revenue

Normalised EPS

ARMO Normalised EPS Unlock ARMO Revenue

PE Ratio Range

ARMO PE Ratio Range Unlock ARMO Revenue

Dividend Yield Range

ARMO Dividend Yield Range Unlock ARMO Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
ARMO EPS Forecasts Unlock ARMO Revenue
Profile Summary

ARMO Biosciences, Inc. is a clinical-stage biopharmaceutical company. The Company focuses on developing immunotherapies for the treatment of cancer, cardiovascular disease, fibrosis and inflammation. The Company's platform molecule AM0010 is a pegylated form of recombinant human IL-10, which has immune stimulating effects that induce the activation, proliferation and survival of intratumoral, tumor-reactive, cytotoxic CD8+ T cells in cancer patients. The Company's has pipeline with an anti-Programmed Cell Death Protein 1 (PD-1) checkpoint inhibitor and therapeutic cytokines. The Company develops pipeline products to use in combination with AM0010, which include AM0015, a Recombinant human Interleukin-15 and AM0012, a Recombinant human Interleukin-12 (AM0012). The Company pipeline also includes AM0001 (anti-PD-1), which is a combination of anti-Programmed Cell Death Protein 1 (PD-1) checkpoint inhibitor and AM0010.

Directors
Last Annual December 31st, 2017
Last Interim March 31st, 2018
Incorporated June 23, 2010
Public Since January 26, 2018
No. of Shareholders: 37
No. of Employees: 31
Sector Healthcare
Industry Biotechnology & Medical Research
Index
Exchange NASDAQ Global Select Market
Shares in Issue 30,405,109
Free Float (0.0%)
Eligible for
ISAs
SIPPs
ARMO Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for ARMO
Upcoming Events for ARMO
Frequently Asked Questions for ARMO Biosciences Inc
What is the ARMO Biosciences Inc share price?

As of 21/06/18, shares in ARMO Biosciences Inc are trading at $49.98, giving the company a market capitalisation of £n/a. This share price information is delayed by 15 minutes.

How has the ARMO Biosciences Inc share price performed this year?

Shares in ARMO Biosciences Inc are currently trading at $49.98 and the price has moved by % over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the ARMO Biosciences Inc price has moved by % over the past year.

What are the analyst and broker recommendations for ARMO Biosciences Inc?

Of the analysts with advisory recommendations for ARMO Biosciences Inc, there are there are currently 0 "buy" , 4 "hold" and 0 "sell" recommendations. The overall consensus recommendation for ARMO Biosciences Inc is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will ARMO Biosciences Inc next release its financial results?

ARMO Biosciences Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2019-03-31
What is the ARMO Biosciences Inc dividend yield?

ARMO Biosciences Inc does not currently pay a dividend.

Does ARMO Biosciences Inc pay a dividend?

ARMO Biosciences Inc does not currently pay a dividend.

When does ARMO Biosciences Inc next pay dividends?

ARMO Biosciences Inc does not currently pay a dividend.

How do I buy ARMO Biosciences Inc shares?

To buy shares in ARMO Biosciences Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of ARMO Biosciences Inc?

Shares in ARMO Biosciences Inc are currently trading at $49.98, giving the company a market capitalisation of £n/a.

Where are ARMO Biosciences Inc shares listed? Where are ARMO Biosciences Inc shares listed?

Here are the trading details for ARMO Biosciences Inc:

Country of listing: United States
Exchange: NSQ
Ticker Symbol: ARMO
What kind of share is ARMO Biosciences Inc?

We were not able to load our ranking data for ARMO Biosciences Inc

Is there a ARMO Biosciences Inc share price forecast 2021?

We were not able to load any forecast data for ARMO Biosciences Inc.

How can I tell whether the ARMO Biosciences Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like ARMO Biosciences Inc. Over the past six months, the relative strength of its shares against the market has been %. At the current price of $49.98, shares in ARMO Biosciences Inc are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the ARMO Biosciences Inc PE Ratio?

We were not able to find PE ratio data for ARMO Biosciences Inc.

Who are the key directors of ARMO Biosciences Inc?

We were unable to find the directors for ARMO Biosciences Inc.

Who are the major shareholders of ARMO Biosciences Inc?

Here are the top five shareholders of ARMO Biosciences Inc based on the size of their shareholding:

Similar to ARMO
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.